logo

For the Inventor, By the Inventor

David L Morse

Tampa, FL, United States of America

David L Morse

LinkedIn
USPTO Granted Patents = 19 

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Tucson, AZ (US) (2010)
  • Stony Point, NY (US) (2020)
  • Tampa, FL (US) (2016 - 2022)

Company Filing History:

goldMedal14 out of 291 
 
H. Lee Moffitt Cancer Center and Research Institute, Inc.
 patents
silverMedal11 out of 973 
 
The University of Arizona
 patents
bronzeMedal5 out of 1,935 
 
University of South Florida
 patents
4. 4 out of 37 
 
Intezyne Technologies, Incorporated
 patents
5. 4 out of 5,470 
 
The University of Texas System
 patents
6. 1 out of 119 
 
The Translational Genomics Research Institute
 patents
7. 3 out of 832,880 
Other
 patents
where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...
19 patents (USPTO):Explore Patents
1. 12186404 - Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer (2025-01-07),
2. 12173087 - Melanocortin 1 receptor ligands and methods of use (2024-12-24),
3. 11458212 - Molecular imaging of cancer cells in vivo (2022-10-04),
4. 11414455 - Toll-like receptor 2 ligands and methods of making and using thereof (2022-08-16),
5. 11406723 - Radiotherapeutic and companion imaging agents to target MC1R (2022-08-09),
6. 11230568 - Melanocortin 1 receptor ligands and methods of use (2022-01-25),
7. 11207429 - Method and compositions for orally administered contrast agents for MR imaging (2021-12-28),
8. 11077212 - Molecular imaging of cancer cells in vivo (2021-08-03),
9. 10793595 - Toll-like receptor 2 ligands and methods of making and using thereof (2020-10-06),
10. 10594235 - Axial flux motor with built-in optical encoder (2020-03-17),
11. 10449227 - Conjugates for immunotherapy (2019-10-22),
12. 10426843 - Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer (2019-10-01),
13. 10406248 - Molecular imaging of cancer cells in vivo (2019-09-10),
14. 10329326 - Melanocortin 1 receptor ligands and methods of use (2019-06-25),
15. 10258607 - Method of increasing intratumoral pHe and reducing acid-mediated invasion (2019-04-16),

Title: The Innovative Journey of David L Morse

Introduction: David L Morse, a pioneering inventor based in Tampa, FL, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: David L Morse holds several patents in various technological domains, including advancements in artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, David L Morse has been at the forefront of innovation, leading research and development teams to create cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, David L Morse has collaborated with top research institutions, leading companies, and brilliant minds in the field to bring his ideas to life and make a lasting impact on the world of technology.

Conclusion: David L Morse's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his position as a visionary inventor, shaping the future of technology for generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…